Harrow, Inc. (HROW)

34.65 -1.70 (-4.68%) USD  |  NASDAQ  |  Mar 09, 14:33
More

Harrow CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Esperion Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade